In the USA, the layoffs at health agencies, proposed tariffs on imports and other disruptive policies under President Donald ...

The uveitis treatment market across seven major economies—the USA, France, Germany, Italy, Spain, the UK, and Japan—is ...

Datroway (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...

Ireland’s government remains confident in its ability to retain the country’s strategic position in pharmaceutical ...

Myricx Bio, a UK biotech focusing on the discovery and development of a novel class of payloads for antibody-drug conjugates ...

Indian drugmaker Sun Pharmaceutical Industries (BSE: 524715) revealed it has launched fexuprazan tablets 40mg in India under ...

US biotech company Vertex Pharmaceuticals (Nasdaq: VRTX) has received European Commission approval to extend the use of its ...

Australia’s Therapeutics Goods Administration (TGA) has issued a safety notice on isotretinoin, originally sold as Roaccutane ...

Following hot on the heels of Monday’s European Commission EC approval of an indication extension for Johnson & Johnson’s ...

US biotech start-up RayThera has secured $110 million in series A financing to fund the early clinical development of its ...

The USA’s Centers for Medicare & Medicaid Services (CMS) yesterday released the Calendar Year (CY) 2026 Rate Announcement for ...

At the recent AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Disease (PD), Cerevance announced that solengepras, a first-in-class G-protein coupled receptor 6 (GPR6) antagonist in ...